Seegene rolls out COVID-19 mutant identification test
Feb. 9, 2021–Seegene announced it has developed the first COVID-19 diagnostic variant test capable of screening COVID-19 and identifying multiple mutant variations in a single reaction.
Webinars and Sponsored Roundtables — Register Now
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
LGC acquires Technopath Clinical Diagnostics
Feb. 5, 2021–LGC announced its acquisition of Technopath Clinical Diagnostics, expanding LGC’s position in the clinical diagnostics QC market.
Sarstedt Microvette automated processing tubes
Feb. 3, 2021–Sarstedt introduced the Microvette APT for capillary blood collection.
Beckman launches tabletop DxH 560 AL hematology analyzer
Jan. 29, 2021—Beckman Coulter launched the DxH 560 AL, a tabletop analyzer geared to reduce the time and resource constraints faced by small to mid-sized laboratories.
Tecan launches automated whole blood processing system
Jan. 22, 2021—Tecan has launched the Fluent Mix and Pierce Workstation to provide end-to-end automation for whole blood pipetting in clinical environments.
PerkinElmer assay gets EUA for asymptomatic testing
Jan. 15, 2021–PerkinElmer announced that its PerkinElmer New Coronavirus Nucleic Acid Detection Kit received emergency use authorization from the FDA to test individuals without symptoms or other reasons to suspect COVID-19 infection.
DiaSorin gets BARDA funding for 510(k) clearance
Jan. 14, 2021–DiaSorin Molecular received additional federal funding from the Biomedical Advanced Research and Development Authority for the validation and submission of the Simplexa COVID-19 Direct kit and the Simplexa COVID-19 & Flu A/B Direct kit for FDA 510(k) clearance.
Sanger Institute’s COSMIC database licensed via Qiagen
Jan. 13, 2021–Qiagen announced that it now retains the exclusive rights to license and distribute the COSMIC database from the Wellcome Sanger Institute for commercial use, effective Jan. 1.
Biocare unveils Oncore Pro IVD platform for IHC, ISH
Jan. 11, 2021–Biocare Medical released its Oncore Pro fully automated slide staining system, a compact, benchtop instrument that performs immunohistochemistry and in situ hybridization procedures on formalin-fixed, paraffin-embedded tissues.
Siemens IL-6 test receives emergency use authorization
Jan. 7, 2021–The FDA has issued an emergency use authorization for Siemens Healthineers’ laboratory-based IL-6 assay to measure the presence of interleukin-6 in human serum or plasma.